Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications
The DOI matches its Crossref record; 168 of the 169 references it cites were found in a registry or an index.
Abstract
Polycystic ovarian syndrome (PCOS) is universally recognised as the commonest endocrinopathy of women. The definition and the aetiological hypotheses of PCOS are continuously evolving to accommodate expanding knowledge on the syndrome, which is now known to be more complex than purely a reproductive disorder. Increased androgen synthesis, disrupted folliculogenesis and insulin resistance lie at the pathophysiological core of PCOS. An intriguing concept involves the perpetuation of a vicious circle with endocrine/reproductive and metabolic components. An unfavourable metabolic environment may unmask genetic traits of ovarian dysfunction, and the unfolding endocrine derangement could further aggravate the metabolic disarray. This article reviews the molecular mechanisms known to underlie the ovarian and metabolic abnormalities characterising PCOS. The putative interdependence between reproductive and metabolic aspects of PCOS, and therapeutic implications for the management of PCOS, are also discussed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recently, advanced glycosylation end products (AGEs) and their receptors implicated in the inflammation and oxidative stress cascades have also been found to be overexpressed in PCOS women [11].”
From Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism (2022) · cites this paper as [11]
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
Azziz, R., Woods, K. S., Reyna, R., Key, T. J., Knochenhauer, E. S., & Yildiz, B. O. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032046 · Cited by 2,712
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143
Self-citationAsunción, M., Calvo, R. M., San Millán, J. L., Sancho, J., Avila, S., & Escobar-Morreale, H. F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6682 · Cited by 1,318
Weenen, C. (2004) · Molecular Human Reproduction · doi:10.1093/molehr/gah015 · Cited by 1,285
TGF-β superfamily members and ovarian follicle development
Knight, P. G., & Glister, C. (2006) · Reproduction · doi:10.1530/rep.1.01074 · Cited by 1,173
Diamanti‐Kandarakis, E., Kouli, C., Bergiele, A. T., Filandra, F. A., Tsianateli, T. C., Spina, G., Zapanti, E. D., & Bartzis, M. I. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.11.4006 · Cited by 1,110 · cited 10×
“References 1 Diamanti-Kandarakis, E. et al. (1999) A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 84, 4006-4011 2 Escobar-Morealle, H. et al. (2000) A prospective study of the prevalence of the polycystic ovary syndrome in unselected Cau…”
BackgroundSelf-citationClomiphene, metformin, or both for infertility in the polycystic ovary syndrome
Legro, R. S., Barnhart, H. X., Schlaff, W. D., Carr, B. R., Diamond, M. P., Carson, S. A., Steinkampf, M. P., Coutifaris, C., McGovern, P. G., Cataldo, N. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063971 · Cited by 1,027 · cited 6×
“Endocr Rev 20, 535-582 12 Legro, R.S. et al. (1998) Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci U S A 95, 14956-14960 13 Nelson, V.L. et al. (1999) Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries…”
BackgroundInfluentialObesity and the polycystic ovary syndrome
Gambineri, A., Pelusi, C., Vicennati, V, Pagotto, U., & Pasquali, R. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0801994 · Cited by 836
The Insulin-Related Ovarian Regulatory System in Health and Disease
Poretsky, L., Cataldo, N. A., Rosenwaks, Z., & Giudice, L. C. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.4.0374 · Cited by 818
Research works printed but not linked: 5
- Jakimiuk, 1999, 5alpha-Reductase activity in women with polycystic ovary syndrome, J Clin Endocrinol Metab, 84, 2414
- 10.1210/jcem.87.3.8316 · doi:10.1210/jcem.87.3.8316 · Paper page
- 10.1210/jcem.84.11.6148 · DOI · Paper page
- Rosenbaum, 1993, Insulin resistance in PCOS: decreased expression of GLUT-4 glucose transporters in adipocytes, Am J Physiol, 264, E197
- 10.1016/j.molmed.2006.05.006 · DOI · Paper page
Cited by
Dumesic, D. A., Oberfield, S. E., Stener-Victorin, E., Marshall, J. C., Laven, J. S., & Legro, R. S. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1018 · Cited by 1,020
Genetic, hormonal and metabolic aspects of PCOS: an update
De Leo, V., Musacchio, M. C., Cappelli, V., Massaro, M. G., Morgante, G., & Petraglia, F. (2016) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-016-0173-x · Cited by 484
“Elevated NGF concentrations in FF have been reported in women with PCOS [59, 71, 78]”
BackgroundInfluentialQiao, J., & Feng, H. L. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmq032 · Cited by 479
“Recent studies suggest that the main FFFs implicated in polycystic ovary folliculogenesis are members of the growth factor families, cytokines, inhibins and others (Franks et al., 2002; Artini et al., 2007; Diamanti-Kandarakis, 2008).”
BackgroundInfluentialStanhewicz, A. E., Wenner, M. M., & Stachenfeld, N. S. (2018) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00396.2018 · Cited by 399
Kandaraki, E., Chatzigeorgiou, A., Livadas, S., Palioura, E., Economou, F., Koutsilieris, M., Palimeri, S., Panidis, D., & Diamanti-Kandarakis, E. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1658 · Cited by 384
“PCOS, characterized by chronic anovulation and hyperandrogenism according to NIH criteria constitutes the most common endocrine disorder of women of reproductive age (20).”
Self-citation
Metadata
- Authors
- Diamanti-Kandarakis, E.
- Venue
- Expert Reviews in Molecular Medicine
- Publisher
- Cambridge University Press (CUP)
- Published
- 2008-01
- Volume
- 10
- Pages
- e3-e3
- ISSN
- 1462-3994 (ISSN-L)
- OpenAlex
- W2105757590
- Cited by
- 294
- References
- 169
- Citations by year
- 2026: 11 · 2025: 20 · 2024: 13 · 2023: 22 · 2022: 20 · 2021: 16 · 2020: 16 · 2019: 17 · 2018: 11 · 2017: 16 · 2016: 18 · 2015: 11 · 2014: 16 · 2013: 13 · 2012: 13
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Expert Reviews in Molecular Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Keywords
- polycystic ovary syndrome, pathophysiology, androgen production, insulin resistance, folliculogenesis, ovarian dysfunction, metabolic dysfunction, molecular mechanisms, PCOS treatment
- MeSH terms
- Androgens, Anovulation, Female, Humans, Ovary, Polycystic Ovary Syndrome, Hyperandrogenism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications. https://app.cochat.ai/papers/10.1017/s1462399408000598
- The paper
- Diamanti-Kandarakis, E. (2008). Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications. Expert Reviews in Molecular Medicine. https://doi.org/10.1017/s1462399408000598
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.